Item 7.01 Regulation FD Disclosure.
Cigna discussed its full year 2020 outlook in its press release and investor
presentation dated
Adjusted revenues is defined as total revenues excluding net realized investment
results from equity method investments and special items. Cigna excludes these
items because management believes they are not indicative of past or future
underlying performance of the business. Adjusted income (loss) from operations
is defined as shareholders' net income (loss) excluding the following
adjustments: net realized investment results, amortization of acquired
intangible assets and special items. Adjusted income (loss) from operations is a
measure of profitability used by Cigna's management because it presents the
underlying results of operations of Cigna's businesses and permits analysis of
trends in underlying revenue, expenses and shareholders' net income. These
consolidated measures are not determined in accordance with accounting
principles generally accepted in
This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this report, except as shall be expressly set forth by specific reference in such a filing.
CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE
SECURITIES LITIGATION REFORM ACT OF 1995
This Current Report on Form 8-K (the "Report"), and oral statements made with
respect to information contained in this Report, may contain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements are based on Cigna's current expectations and
projections about future trends, events and uncertainties. These statements are
not historical facts. Forward-looking statements may include, among others,
statements relating to our projected full year 2020 adjusted revenues and
projected full year 2020 and 2021 consolidated adjusted income from operations
on a per share basis as reflected in Item 7.01 of this Report, as well as
statements made in our press release and investor presentation dated
-2-
Forward-looking statements are subject to risks and uncertainties, both known
and unknown, that could cause actual results to differ materially from those
expressed or implied in forward-looking statements. Such risks and uncertainties
include, but are not limited to: our ability to achieve our financial, strategic
and operational plans or initiatives; our ability to predict and manage medical
and pharmacy costs and price effectively; our ability to adapt to changes or
trends in an evolving and rapidly changing industry; our ability to effectively
differentiate our products and services from those of our competitors and
maintain or increase market share; our ability to develop and maintain good
relationships with physicians, hospitals, other health care providers,
producers, consultants and pharmaceutical manufacturers; changes in the pharmacy
provider marketplace or pharmacy networks; changes in drug pricing; the impact
of modifications to our operations and processes; our ability to identify
potential strategic transactions and realize the expected benefits (including
anticipated synergies) of such transactions in full or within the anticipated
time frame, including with respect to the Merger and the sale of our Group
Disability and Life business, as well as our ability to integrate or separate
operations, resources and systems; the substantial level of government
regulation over our business and the potential effects of new laws or
regulations or changes in existing laws or regulations; the outcome of
litigation, regulatory audits, investigations, actions or guaranty fund
assessments; uncertainties surrounding participation in government-sponsored
programs such as Medicare; the effectiveness and security of our information
technology and other business systems and those of our key suppliers or other
third parties; the impact of our debt service obligations on the availability of
funds for other business purposes; unfavorable industry, economic or political
conditions, including foreign currency movements; acts of civil unrest, war,
terrorism, natural disasters or pandemics; reinsurance credit risk, the scale
and scope of the COVID-19 pandemic and its potential impact on our business,
operating results, cash flows and financial condition, as well as on our
employees, clients, customers, suppliers and partners and on the
-3-
© Edgar Online, source